Literature DB >> 9614101

Cyclin D3 is rate-limiting for the G1/S phase transition in fibroblasts.

T Herzinger1, S I Reed.   

Abstract

D-type cyclins are induced in response to mitogens and are believed to control progression through the G1 phase of the cell cycle by activating their corresponding kinase partners (cyclin-dependent kinases). To investigate the function of individual D-type cyclins we have constructed rat fibroblast lines that allow controllable overexpression of a human cyclin D3 cDNA. Overexpression of cyclin D3 led to accelerated passage through G1 in actively proliferating cells with no effect on the overall population doubling time. In cells re-entering the division cycle from a quiescent state, cyclin D3 caused an even more dramatic advancement of S phase entry. Accelerated progression through G0/G1-to-S correlated with premature phosphorylation of the pRb tumor suppressor protein and its relatives, p107 and p130. We conclude that cyclin D3 can act as a rate-limiting G1 cyclin and that this effect involves, in part, the premature phosphorylation of critical substrates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614101     DOI: 10.1074/jbc.273.24.14958

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 2.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines.

Authors:  Guo-Li Wang; Xiurong Shi; Elizabeth Salisbury; Nikolai A Timchenko
Journal:  Exp Cell Res       Date:  2008-02-13       Impact factor: 3.905

4.  Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism.

Authors:  M Artwohl; C Fürnsinn; W Waldhäusl; T Hölzenbein; G Rainer; A Freudenthaler; M Roden; S M Baumgartner-Parzer
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

5.  p65 Negatively regulates transcription of the cyclin E gene.

Authors:  Vaibhao C Janbandhu; Anup K Singh; Atish Mukherji; Vijay Kumar
Journal:  J Biol Chem       Date:  2010-04-11       Impact factor: 5.157

6.  Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin.

Authors:  B A Wilson; L R Aminova; V G Ponferrada; M Ho
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.

Authors:  Guo-Li Wang; Xiurong Shi; Elizabeth Salisbury; Yuxiang Sun; Jeffrey H Albrecht; Roy G Smith; Nikolai A Timchenko
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Increased expression of CDK11p58 and cyclin D3 following spinal cord injury in rats.

Authors:  Yuhong Ji; Feng Xiao; Linlin Sun; Jing Qin; Shuxian Shi; Junling Yang; Yonghua Liu; Dan Zhou; Jian Zhao; Aiguo Shen
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

9.  SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells.

Authors:  Serena Bonifati; Michele B Daly; Corine St Gelais; Sun Hee Kim; Joseph A Hollenbaugh; Caitlin Shepard; Edward M Kennedy; Dong-Hyun Kim; Raymond F Schinazi; Baek Kim; Li Wu
Journal:  Virology       Date:  2016-05-14       Impact factor: 3.616

10.  A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium.

Authors:  Ekaterini Angelis; Alejandro Garcia; Shing S Chan; Katja Schenke-Layland; Shuxen Ren; Sarah J Goodfellow; Maria C Jordan; Kenneth P Roos; Robert J White; W Robb MacLellan
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.